Medtronic (MDT) Other financing activities (2014 - 2026)

Medtronic has disclosed Other financing activities across 13 years of filings, most recently posting $13.0 million for Q3 2026.

• In Q3 2026, Other financing activities fell 81.43% year-over-year to $13.0 million; the TTM figure through Jul 2026 stood at $481.0 million (up 585.86% YoY), while the FY2026 annual figure was $538.0 million, up 392.39% from the prior year.
• Other financing activities came in at $13.0 million for Q3 2026 at Medtronic, down from $478.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $478.0 million in Q2 2026 to a low of -$719.0 million in Q1 2023.
• Average Other financing activities over 5 years is $8.6 million, with a median of -$5.0 million recorded in 2025.
• Year-over-year, Other financing activities surged 6925.0% in 2022 and plunged 11883.33% in 2023.
• Over 5 years, Other financing activities stood at $170.0 million in 2022, then fell by 5.29% to $161.0 million in 2023, then plunged by 130.43% to -$49.0 million in 2024, then jumped by 89.8% to -$5.0 million in 2025, then soared by 360.0% to $13.0 million in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $13.0 million in Q3 2026, $478.0 million in Q2 2026, and -$5.0 million in Q1 2026.